thiscart19a
Showing 1 - 4 of 4
Refractory or Relapsed B Cell Lymphoma Trial in Chongqing (ThisCART19A, Fludarabine, Cyclophosphamide)
Not yet recruiting
- Refractory or Relapsed B Cell Lymphoma
- ThisCART19A
- +3 more
-
Chongqing, Chongqing, ChinaChongqing University Cancer Hospital
Mar 8, 2023
Allogeneic, CAR-T, Protein Sequestration, Non-gene Edited Trial in Zhengzhou (ThisCART19A, Fludarabine Pill, Cyclophosphamide)
Not yet recruiting
- Allogeneic, CAR-T, Protein Sequestration, Non-gene Edited
- ThisCART19A
- +3 more
-
Zhengzhou, Henan, ChinaHenan cancer hospital
Nov 28, 2022
Allogeneic, CAR-T, Protein Sequestration, Non-gene Edited, r/r B-NHL Trial (ThisCART19A)
Not yet recruiting
- Allogeneic, CAR-T, Protein Sequestration, Non-gene Edited, r/r B-NHL
- ThisCART19A
- (no location specified)
Sep 9, 2022
Allogeneic, CAR-T, Protein Sequestration, Non-gene Edited Trial (ThisCART19A, Fludarabine Oral Tablet, Cyclophosphamide)
Not yet recruiting
- Allogeneic, CAR-T, Protein Sequestration, Non-gene Edited
- ThisCART19A
- +4 more
- (no location specified)
Oct 8, 2022